The miR-100-5p Targets SMARCA5 to Regulate the Apoptosis and Intracellular Survival of BCG in Infected THP-1 Cells

Author:

Su Li12,Zhu Tingting12,Liu Han12,Zhu Yifan12,Peng Yongchong12,Tang Tian12,Zhou Shiying12,Hu Changmin12,Chen Huanchun12,Guo Aizhen1234,Chen Yingyu1234

Affiliation:

1. The State Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan 430070, China

2. Key Laboratory of Development of Veterinary Diagnostic Products, Ministry of Agriculture and Rural Affairs, Huazhong Agriculture University, Wuhan 430070, China

3. National Professional Laboratory for Animal Tuberculosis (Wuhan), Ministry of Agriculture and Rural Affairs, Huazhong Agriculture University, Wuhan 430070, China

4. Hubei International Scientific and Technological Cooperation Base of Veterinary Epidemiology, Hubei Hongshan Laboratory, Huazhong Agricultural University, Wuhan 430070, China

Abstract

Mycobacterium tuberculosis (M. tb) is the causative agent of tuberculosis (TB) that leads to millions of deaths each year. Extensive evidence has explored the involvement of microRNAs (miRNAs) in M. tb infection. Limitedly, the concrete function of microRNA-100-5p (miR-100-5p) in M. tb remains unexplored and largely elusive. In this study, using Bacillus Calmette–Guérin (BCG) as the model strain, we validated that miR-100-5p was significantly decreased in BCG-infected THP-1 cells. miR-100-5p inhibition effectively facilitated the apoptosis of infected THP-1 cells and reduced BCG survival by regulating the phosphatidylinositol 3-kinase/AKT pathway. Further, SMARCA5 was the target of miR-100-5p and reduced after miR-100-5p overexpression. Since BCG infection down-regulated miR-100-5p in THP-1 cells, the SMARCA5 expression was up-regulated, which in turn increased apoptosis through caspase-3 and Bcl-2 and, thereby, reducing BCG intracellular survival. Collectively, the study uncovered a new molecular mechanism of macrophage to suppress mycobacterial infection through miR-100-5p and SMARCA5 pathway.

Funder

National Key Research and Development Programme of China

National Natural Science Foundation of China

Natural Science Foundation of Hubei Province

China Agricultural Research System

Publisher

MDPI AG

Subject

General Medicine

Reference41 articles.

1. WHO (2021, May 13). Global Tuberculosis Report 2020. Available online: https://www.who.int/publications/i/item/9789240013131.

2. The future for early-stage tuberculosis drug discovery;Zuniga;Future Microbiol.,2015

3. MicroRNA-27b Modulates Inflammatory Response and Apoptosis during Mycobacterium tuberculosis Infection;Liang;J. Immunol.,2018

4. Galectins Control mTOR in Response to Endomembrane Damage;Jia;Mol. Cell,2018

5. Apoptosis inhibition by intracellular bacteria and its consequence on host immunity;Behar;Curr. Opin. Immunol.,2019

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

全球学者库

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2023 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3